VPM-p15 is a protease-sensitive peptide designed for controlled degradation in biomaterial systems. Its sequence incorporates residues that modulate susceptibility to matrix metalloproteinases. Researchers study cleavage kinetics and structural stability within engineered matrices. Applications include responsive hydrogel design, targeted-release systems, and biomaterial functionalization.
VPM-p15 is a specialized carbohydrate compound designed for advanced research applications in the fields of molecular biology, tissue engineering, and biomaterials science. As a synthetic peptide-mimetic glycan, it features a unique sequence that mimics natural extracellular matrix components, enhancing its ability to interact with cell surface receptors and influence cellular behavior. The structure of VPM-p15 allows it to participate in a range of biological processes, making it a valuable tool for researchers seeking to elucidate the complex interactions between cells and their microenvironment. Its versatility and biocompatibility have established VPM-p15 as a preferred choice in experimental settings where modulation of cell adhesion, migration, and differentiation is essential.
Tissue Engineering Scaffolds: In tissue engineering, VPM-p15 serves as an integral component of scaffold materials designed to support cell growth and tissue regeneration. By incorporating this glycopeptide into hydrogels or porous matrices, researchers can enhance the bioactivity of scaffolds, promoting cell attachment and proliferation. Its ability to mimic natural extracellular matrix signals enables more physiologically relevant cellular responses, facilitating the development of engineered tissues with improved structural and functional properties. The incorporation of VPM-p15 into scaffold systems is especially valuable for studies focused on bone, cartilage, and soft tissue regeneration, where precise control over cell-matrix interactions is critical.
Cell Culture Substrates: As a cell culture substrate, the compound provides a biologically active surface that supports the adhesion and spreading of various cell types, including stem cells and primary cells. By coating culture dishes or microcarriers with VPM-p15, scientists can create an environment that closely resembles in vivo conditions, thereby improving cell viability and maintaining desired phenotypic characteristics. This approach is particularly beneficial in stem cell research, where maintaining pluripotency or directing differentiation requires finely tuned extracellular cues. The use of this carbohydrate compound in cell culture systems also facilitates high-throughput screening and reproducible experimental outcomes.
Controlled Drug Delivery: VPM-p15 is widely utilized in the development of controlled drug delivery systems, where its biocompatibility and tunable degradation properties are leveraged to achieve sustained release of therapeutics. By conjugating drugs or growth factors to the glycopeptide or embedding it within biodegradable carriers, researchers can design delivery vehicles that respond to physiological triggers, such as enzymatic activity or pH changes. This targeted approach minimizes off-target effects and enhances the therapeutic efficacy of bioactive molecules. The versatility of VPM-p15 in drug delivery research extends to applications in regenerative medicine, wound healing, and localized therapy.
Biomaterials Research: In the field of biomaterials, VPM-p15 is employed to modify the surface properties of implants and medical devices, improving their integration with host tissues. Surface functionalization with this carbohydrate compound can reduce non-specific protein adsorption, decrease immune responses, and promote the recruitment of specific cell types to the implant site. These modifications are crucial for the development of next-generation biomaterials with enhanced biocompatibility and reduced risk of adverse reactions. The ability of VPM-p15 to mediate cell-material interactions makes it a valuable asset in the design of innovative biomedical devices.
Enzyme-Responsive Systems: The unique sequence of VPM-p15 allows it to be selectively cleaved by specific enzymes, enabling the creation of enzyme-responsive systems for a variety of research applications. In such systems, the glycopeptide acts as a molecular switch, releasing bioactive agents or altering material properties in response to enzymatic activity. This functionality is particularly useful in the development of smart biomaterials that can adapt to changing biological environments, such as those encountered in tissue remodeling or wound healing scenarios. The integration of VPM-p15 into enzyme-responsive platforms provides researchers with a powerful tool for studying dynamic biological processes and designing adaptive therapeutic systems.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More